Artelo Biosciences, Inc. (ARTL) Stock
Healthcare · Biotechnology · Member of Other US Stocks
Artelo Biosciences, Inc. (ARTL) closed at USD 2.88 on 2026-10-14, a change of -97 % over the past year, with a market capitalization of USD 1.5M.
Artelo Biosciences, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 2.88 |
| 2026-10-13 | 2.98 |
| 2026-10-12 | 3.11 |
| 2026-10-09 | 3.26 |
| 2026-10-08 | 3.37 |
| 2026-10-07 | 3.41 |
| 2026-10-06 | 3.46 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Artelo Biosciences, Inc. key figures
- Previous close
- USD 2.88 (2026-10-14)
- 1-year change
- -97 %
- Market cap
- USD 1.5M
- Enterprise value
- USD -2.75M
- P/E ratio (trailing)
- -0.02
- P/E ratio (forward)
- -3.11
- EPS (trailing)
- -140.64
- EPS (forward)
- -0.88
- PEG ratio
- n/a
- Price to book
- 0.26
- Revenue growth
- n/a
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.04
- Employees
- 7
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Artelo Biosciences, Inc.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Artelo Biosciences, Inc. and compare it with other stocks.
Analyze ARTLAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Artelo Biosciences, Inc. shares.